Delivery Order SPE2D020D0014-SPE2D325F269B
- Not listed
- The Defense Logistics Agency Troop Support Medical awarded a $132,400 firm fixed price delivery order to Pfizer Inc. for 2,000 vials of SOLU-MEDROL (methylprednisolone sodium succinate for injection, USP), a corticosteroid medication. Pfizer will deliver the products from its New York location by July 24, 2023 to support DLA Troop Support Medical programs. No subcontractors or set aside designations were identified. DLA Troop Support Medical manages the global supply chain for the Department...
- The Defense Logistics Agency Troop Support Medical awarded a $132,400 firm fixed price delivery order to Pfizer Inc., doing business as Pfizer, for 2,000 vials of SOLU-MEDROL (methylprednisolone sodium succinate) injectable medication. The place of performance is Pfizer's New York City location. The delivery order period of performance is July 6-11, 2023. DLA Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical supplies. This delivery order...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,660.71 firm-fixed-price delivery order is for the supply of SOLU-MEDROL 40 MG VIALS, with a completion date of October 25, 2024. This award does not have a set-aside designation, indicating open competition. The contract is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Solu-Medrol 40 mg vials valued at $5,223.67 with a firm fixed price structure. The contract, with an ultimate completion date of August 8, 2025, represents a competitively awarded, non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,805.42 firm fixed-price delivery order is for SOLU-MEDROL 125 MG VIALS, with an ultimate completion date of November 8, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds significant indefinite delivery contracts (IDCs) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,066.83, is for the delivery of 2,000 mg SOLU-MEDROL vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,710.44 firm fixed-price delivery order is for the supply of SOLU-MEDROL 125 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of October 31, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award, valued at $1,787.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4558492535 - SOLU-MEDROL 40 MG VIALS. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC, valued at up to $999,999,999, serves as the primary vehicle for AmerisourceBergen to provide a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Solu-Medrol 125 mg vials, with a ceiling value of $6,564.16 and an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The product will be delivered to the vendor's corporate office...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 mg vials of the drug SOLU-MEDROL, with a ceiling value of $1,314.45 and a completion date of June 4, 2025. The contract is not set aside and was competed openly. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- SPE2D020D0014Indefinite Delivery Contract
- SPE2D020D0014-SPE2D325F269BDelivery Order
Pfizer Inc. was awarded a delivery order valued at $1,362.06 by the Medical Supply Chain, a component of the Defense Logistics Agency Troop Support, for the supply of Solu-Medrol 500 mg vials. This firm fixed-price contract was executed on July 28, 2025, with an ultimate completion date of July 29, 2025, and was performed in New York, New York. No small business set-aside designation was utilized for this award, reflecting Pfizer's status as an established large pharmaceutical manufacturer. Solu-Medrol, a corticosteroid injection, represents a critical pharmaceutical product within the federal government's medical supply procurement framework for defense and healthcare applications. This delivery order exemplifies Pfizer's role as a strategic supplier within the federal medical supply infrastructure. The company holds substantial indefinite delivery vehicle contracts with federal agencies, including a $74.0 million IDV for Rituximab and biosimilar products and a $46.9 million IDV for Bevacizumab injections serving multiple federal healthcare organizations including the Department of Veterans Affairs, Department of Defense, and the Indian Health Service. Through the Medical Supply Chain prime vendor program, Pfizer consistently delivers injectable medications and pharmaceutical preparations essential to federal government healthcare operations, demonstrating its long-term commitment to supporting critical medical interventions across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/28/25 |